SCHEMBL6274445

SCHEMBL6274445

CCOc1c(O)c2cc(OCCCCO)ccc2oc1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO1 P15559 1/20 0.46
▸ KDM4E B2RXH2 5/20 0.45
▸ ALDH1A1 P00352 4/20 0.45
▸ HPGD P15428 4/20 0.45
▸ GAA P10253 2/20 0.43
▸ CA12 O43570 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ ALDH2 P05091 3/20 0.42
▸ SIGMAR1 Q99720 1/20 0.41
▸ ACSL1 P33121 2/20 0.41
▸ ACSL6 Q9UKU0 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ MAPK1 P28482 1/20 0.40
▸ RECQL P46063 1/20 0.40
▸ MAOA P21397 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6276642 0.96 NQO1 (0.47) NQO1KDM4EALDH1A1HPGDGAA
SCHEMBL6274551 0.93 NQO1 (0.46) NQO1KDM4EALDH1A1HPGDCA12
SCHEMBL6273114 0.93 NQO1 (0.48) NQO1KDM4EALDH1A1HPGDGAA
SCHEMBL6276165 0.91 MAOA (0.47) NQO1CA12CA9ALDH2SIGMAR1
SCHEMBL6277193 0.91 MAOA (0.47) NQO1CA12CA9ALDH2SIGMAR1
SCHEMBL6274729 0.91 KDM4E (0.51) NQO1KDM4EALDH1A1HPGDGAA
SCHEMBL6273131 0.89 NQO1 (0.47) NQO1KDM4EALDH1A1HPGDGAA
SCHEMBL6274463 0.88 MAOA (0.47) NQO1CA12CA9ALDH2SIGMAR1
SCHEMBL6277707 0.88 MAOA (0.47) NQO1CA12CA9ALDH2SIGMAR1
SCHEMBL6273132 0.88 MAOA (0.47) NQO1CA12CA9ALDH2SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1273578-B1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK & CHEMICALS (JP) 2005-02-23 — — EP disclosed
US-6670391-B2 For inhibiting both immediate and delayed type allergic reactions; side effect reduction DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-12-30 — — US disclosed
US-20030096860-A1 Benzopyran derivative and antiallergic agent DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-05-22 — — US disclosed
EP-1273578-A1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096860-A1 Benzopyran derivative and antiallergic agent HRH2, HRH1, HRH4 NQO1 1320/4885KDM4E 965/4885ALDH1A1 105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback